retatrutide study results Looking forward to when #retatrutide's Phase 3 trial will become available. There are are 4 planned TRIUMPH trials investigating retatrutide's efficacy in treating obesity and its complications: #type2diabetes #cardiovascular disease Percent of participants achieving liver

POWERED BY Storyful Intelligence This analysis uses Storyfuls proprietary systems for revealing how narratives form and spread across ecosystems

For a drug to be approved for the pregnant population, it must go through rigorous testing with that population, and that has not yet happened for semaglutide or other GLP-1 (glucagon-like peptide 1) agonists, says Carrie Burns , MD, a board-certified endocrinologist and director of diabetes in pregnancy at Penn Medicine in Philadelphia

Get an extra 25% off plans when this coupon code is applied

Research peptides in pharma-grade quality For research applications, peptide purity is essential for reliable results

doi: 10.2174/138920012802850146

Oshis team understands what patients struggling with GI symptoms, including those taking GLP-1s, need: Integrated multidisciplinary care: Patients should receive coordinated care addressing each of their needs, with support from GI providers for diagnosis and medication, registered dietitians to pair GLP-1s with the right diet for sustainable improvement, behavioral health specialists to ease the anxiety around GLP-1 side effects for adherence, and care coordinators to work with their existing GLP-1 provider